Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jun 03, 2024

BUY
$20.94 - $38.01 $223,220 - $405,186
10,660 New
10,660 $381,000
Q1 2023

May 28, 2024

BUY
$22.92 - $33.76 $244,327 - $359,881
10,660 New
10,660 $249,000
Q1 2021

May 05, 2021

SELL
$127.04 - $179.1 $3 Million - $4.23 Million
-23,644 Reduced 68.92%
10,660 $1.63 Million
Q1 2020

Apr 27, 2020

SELL
$59.04 - $88.81 $5 Million - $7.51 Million
-84,615 Reduced 71.15%
34,304 $2.39 Million
Q4 2019

Jan 31, 2020

SELL
$59.49 - $82.78 $4.31 Million - $6 Million
-72,470 Reduced 37.87%
118,919 $9.29 Million
Q3 2019

Nov 13, 2019

BUY
$62.59 - $110.3 $12 Million - $21.1 Million
191,389 New
191,389 $12.2 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.38B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.